When Making Babies Goes High Tech: A Future Tense Event Recap
By Ariel Bogle,
Slate
| 11. 24. 2014
[Quotes CGS's Marcy Darnovsky]
Untitled Document
In vitro fertilization was originally intended to help a very specific young, married, and female demographic to conceive. But a lot has changed since Louise Brown, the first test tube baby, was born in 1978. The explosion of single mothers and same-sex parents using the procedure has attracted a lot of attention, but society also needs to grapple with the questions of control, regulation, and access that other emerging reproductive technologies could raise. From pre-implantation genetic screening to exo-wombs, these changes could even evolve our most basic notions of family and society.
A first step may be agreeing to talk about this possible future at all. The highly personal nature of reproductive science and technology makes it a difficult topic to discuss and legislate, according to speakers at a Future Tense event on the future of reproduction in Washington, D.C., last week. After all, we’re not talking about hip replacement surgery; this is our future children and grandchildren. As Dieter Egli, a senior research fellow at the New York Stem Cell Foundation, put it: “When we touch the...
Related Articles
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...
By Antonio Regalado, MIT Technology Review | 10.31.2025
A West Coast biotech entrepreneur says he’s secured $30 million to form a public-benefit company to study how to safely create genetically edited babies, marking the largest known investment into the taboo technology.
The new company, called Preventive, is...
By Emily Mullin, Wired | 10.30.2025
In 2018, Chinese scientist He Jiankui shocked the world when he revealed that he had created the first gene-edited babies. Using Crispr, he tweaked the genes of three human embryos in an attempt to make them immune to HIV and...